The Drug Eluting Stents Center

Filter Your Results




Understanding Benefits and Risks of Drug-Eluting Stents

Ian T. Meredith, MBBS, PhD, AM

June 2019—Ongoing clinical studies will shed light on patient outcomes in real-world settings.

The SAVAL Trial

Jihad A. Mustapha, MD, FACC, FSCAI; Patrick Geraghty, MD, FACS; and Hans van Overhagen, MD, PhD, EBIR

May 2019—Details on the design and rationale behind this randomized trial studying infrapopliteal drug-eluting stent use for critical limb ischemia.

FDA Paclitaxel Safety Panel Preview

Kenneth Cavanaugh, PhD; and Misti Malone, PhD

May 2019—An interview with FDA CDRH representatives discussing the upcoming advisory panel meeting to review concerns and current data on paclitaxel-eluting device use.

Highlights From the VIVA Vascular Leaders Forum on Paclitaxel Safety

March 2019—Points of consensus, contention, and paths forward.

On the Paclitaxel Meta-Analysis: A Conversation With Konstantinos Katsanos, MD

March 2019—Dr. Katsanos discusses the methods and findings of his group’s meta-analysis, the patient-level data presented in response, and potential next steps.

A Roundtable Discussion on Results From the First Head-to-Head DES SFA Trial: IMPERIAL

With Michael R. Jaff, DO; Gary M. Ansel, MD, FACC; William A. Gray, MD; Steve Henao, MD, FACC, FACS; and Robert A. Lookstein, MD

January 2019—A multidisciplinary panel of PAD experts discuss the impact on patient care and the health care system and how these results may shift current treatment algorithms.

Discussing the IMPERIAL Data in Practice

With Yann Gouëffic, MD, PhD; and Andrew Holden, MBChB, FRANZCR, EBIR

January 2019—Two vascular experts share their reactions to hearing the results of the first head-to-head peripheral DES trial.

IMPERIAL 12-Month Full Cohort and Long Lesion Sub-Study Results

William A. Gray, MD; Additional commentary by Prof. Stefan Müller-Hülsbeck, MD, EBIR, FCIRSE, FICA, FSIR

January 2019—Sustained drug-release in the SFA drives superior results.




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.